ATNM

1.31

6.50% 0.08

Dopo l'orario di chiusura: 1.26 -0.05 -3.82%

Actinium Pharmaceuticals Inc (ATNM)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Forum Previsione Frazionamento azionario

Precedente Chiudi:

$1.23

Aprire:

$1.25

Volume 24 ore:

226.55K

Relative Volume:

1.60

Capitalizzazione di mercato:

$41.19M

Reddito:

$90,000

Utile/perdita netta:

$-23.47M

Rapporto P/E:

-1.7416

EPS:

-0.7522

Flusso di cassa netto:

$-22.98M

1 W Prestazione:

+24.76%

1M Prestazione:

+70.09%

6M Prestazione:

+8.26%

1 anno Prestazione:

-18.63%

Intervallo 1D:

$1.2301

$1.34

Intervallo di 1 settimana:

$1.02

$1.34

Portata 52W:

$0.7351

$1.74

Actinium Pharmaceuticals Inc Stock (ATNM) Company Profile

Nome

Actinium Pharmaceuticals Inc

Settore

Healthcare (1069)

Industria

Biotechnology (595)

Telefono

646-767-3870

Indirizzo

275 Madison Avenue, 7th Floor, New York, NY

Dipendente

Cinguettio

@actiniumpharma

Prossima data di guadagno

2026-08-14

Ultimi documenti SEC

ATNM's Discussions on Twitter

Compare ATNM vs VRTX, REGN, ARGX, MRNA, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ATNM Actinium Pharmaceuticals Inc	1.31	38.67M	90,000	-23.47M	-22.98M	-0.7522
VRTX Vertex Pharmaceuticals Inc	514.56	132.08B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	793.26	83.15B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	984.04	62.71B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	136.62	54.14B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	203.35	44.51B	742.00K	-1.37B	-1.07B	-7.0731

Actinium Pharmaceuticals Inc Stock (ATNM) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-08-07	Downgrade	B. Riley Securities	Buy → Neutral
2024-05-14	Iniziato	Stephens	Overweight
2023-09-06	Iniziato	HSBC Securities	Buy
2023-02-21	Downgrade	William Blair	Outperform → Mkt Perform
2022-09-08	Iniziato	Cantor Fitzgerald	Overweight
2022-08-25	Iniziato	B. Riley Securities	Buy
2020-11-05	Iniziato	Alliance Global Partners	Buy
2017-12-06	Iniziato	B. Riley FBR, Inc.	Buy
2017-10-23	Ripresa	ROTH Capital	Buy
2017-09-14	Iniziato	Maxim Group	Buy
2016-08-25	Iniziato	ROTH Capital	Buy
2016-02-29	Iniziato	H.C. Wainwright	Buy
2015-10-15	Iniziato	FBR Capital	Outperform
2014-10-01	Iniziato	MLV & Co	Buy
2014-07-22	Iniziato	Canaccord Genuity	Buy

Mostra tutto

Actinium Pharmaceuticals Inc Borsa (ATNM) Ultime notizie

Sep 04, 2026

Actinium CEO to present at H.C. Wainwright Glob... - Pluang

Sep 04, 2026

Actinium Pharmaceuticals, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference - PR Newswire

Sep 04, 2026

Actinium Pharmaceuticals (ATNM) grants director new stock awards - Stock Titan

Sep 04, 2026

Actinium Pharmaceuticals (ATNM) grants director $1.00 options and RSUs - Stock Titan

Sep 04, 2026

Aug 23, 2026

Actinium (ATNM) Update: Slides 1.79% to $1.10 in Latest Trading; Next Test: Traders Can Monitor the $1.04-$1.16 Range in the Latest SessionBreakout Confirmation - vinanet.vn

Aug 23, 2026

Aug 19, 2026

Actinium (ATNM) Chart: Ends Up by 3.24% at $1.11 in Latest Trading; Level Watch: the Supplied Trading Band Runs From $1.05 to $1.17Up Down Ratio - vinanet.vn

Aug 19, 2026

KPTI Stock Price and Chart — NASDAQ:KPTI - TradingView

Aug 19, 2026

ETFs Investing in Actinium Pharmaceuticals, Inc. Stocks - TradingView

Aug 19, 2026

Aug 15, 2026

Analysts Are Bullish on Top Healthcare Stocks: BridgeBio Pharma (BBIO), Pyxis Oncology (PYXS) - The Globe and Mail

Aug 15, 2026

Aug 14, 2026

Form 8K Actinium Pharmaceuticals Inc For: 14 August By Investing.com - Investing.com Nigeria

Aug 14, 2026

Actinium Pharmaceuticals Announces Actimab-A Intellectual Property And Manufacturing Advances And Provides NYSE American Listing Update - TradingView

Aug 14, 2026

Actinium Pharmaceuticals Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

Aug 14, 2026

Actinium Pharmaceuticals Announces Actimab-A Intellectual Property and Manufacturing Advances and Provides NYSE American Listing Update - PR Newswire

Aug 14, 2026

Aug 12, 2026

Actinium Pharmaceuticals (ATNM) Institutional Ownership 2026 - MarketBeat

Aug 12, 2026

Aug 10, 2026

Actinium Pharmaceuticals (ATNM) Slips 3.4% to $0.77 as Key Support at $0.73 Comes into FocusInstitutional Sentiment - dars.gov.et

Aug 10, 2026

Aug 05, 2026

Actinium Pharmaceuticals (ATNM) Falls 7.5% to $0.75 as Selling Pressure IntensifiesGrowth ETF - dars.gov.et

Aug 05, 2026

Aug 03, 2026

Levi & Korsinsky Notifies Actinium Pharmaceuticals, Inc. (ATNM) InvestorsLead Plaintiff Deadline on May 27, 2025 - The National Law Review

Aug 03, 2026

Aug 01, 2026

Actinium Pharmaceuticals, Inc. (Delaware) Revenue Breakdown – AMEX:ATNM - TradingView

Aug 01, 2026

Jul 28, 2026

Actinium Pharmaceuticals (ATNM) Edges Higher as Stock Holds Above Key SupportInitial Balance - dars.gov.et

Jul 28, 2026

Jul 27, 2026

Class Action Lawsuit Filed: Actinium Pharmaceuticals, Inc. (ATNM)Join by May 27, 2025Contact Levi & Korsinsky - The National Law Review

Jul 27, 2026

Jul 26, 2026